Diabetes
-
Eli Lilly inks partnership deal with Cipla for key diabetes drugs
INDIA – The Indian arm of North American drugmaker Eli Lilly has announced a strategic partnership with Indian pharmaceutical Cipla, allowing the latter to sell,…
-
Zydus Cadila gets USFDA’s approval to market diabetes medication
INDIA – Drug firm Zydus Cadila has received approval from the US health regulator to market Sitagliptin, a medicine indicated to treat diabetes. The company…
-
Sigh of relief for people with diabetes as FDA approves first biosimilar insulin product
US – The U.S. Food and Drug Administration (FDA) has approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and…
-
Bayer’s Kerendia can now be used in USA as therapy for chronic kidney disease in type 2 diabetes patients
US – Bayer’s first-in-class nonsteroidal drug Kerendia is now available in the US for use following an approval as a therapy that can slow chronic…
-
Diabetes tech market continues to witness an upward trend as more companies are coming up with new innovations
US – Despite the volatility of last year’s economy due to the corona virus pandemic, diabetes technology companies experienced tremendous success. Analysts have been bullish…
-
Lilly’s tirzepatide tops list ahead of ozempic as treatment candidate for type 2 diabetes
US – In the just concluded phase 3 trials, the American pharmaceutical company, Eli Lilly have provided results that showed its investigational Gastric inhibitory polypeptide…